IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

196.75

-1.07 (-0.54%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	200.84
Open	198.27
Bid	177.05 x 100
Ask	210.00 x 100
Day's Range	195.81 - 198.66
52 Week Range	146.09 - 207.14
Volume	278,868
Avg. Volume	546,550

Market Cap	17.129B
Beta	0.64
PE Ratio (TTM)	66.92
EPS (TTM)	2.94
Earnings Date	May 4, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	200.86

Trade prices are not sourced from all markets

All

News

Press Releases

PR Newswire10 days ago
IDEXX Laboratories to Release 2018 First Quarter Financial Results
WESTBROOK, Maine, April 12, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 first quarter financial results for Friday, May 4 before the market opens. Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. To listen to the live conference call, please dial 1-800-288-8967 or 1-612-234-9960 and reference confirmation code 447373.
Thomson Reuters StreetEvents12 days ago
Edited Transcript of IDXX presentation 6-Mar-17 3:25pm GMT
IDEXX Laboratories Inc at Raymond James Institutional Investors Conference
Zacks20 days ago
The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions
The Zacks Analyst Blog Highlights: Seagate Technology, Micron Technology, IDEXX Laboratories, Kohl's and Motorola Solutions
Zacks24 days ago
5 Top-Performing S&P 500 Stocks of Q1
We have highlighted five S&P 500 stocks that have dished out double-digit returns in Q1 and remained undisturbed by higher bouts of volatility
Markit26 days ago
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX. Over the last one-month, outflows of investor capital in ETFs holding IDXX totaled $3.36 billion.
Zackslast month
Why Should You Add IDEXX (IDXX) Stock to Your Portfolio?
IDEXX (IDXX) might gain from the commercial launch of Catalyst SDMA Test in North America. As a result, its point-of-care customers can add SDMA as an essential element to the routine chemistry panel.
Markitlast month
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
Idexx Laboratories Inc NASDAQ/NGS:IDXX
Zackslast month
IDEXX Laboratories Gains on Solid Prospects & CAG Business
IDEXX Laboratories (IDXX) continues to boost investor confidence in strong companion animal business along with attractive global prospects.
Markitlast month
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX. Over the last one-month, outflows of investor capital in ETFs holding IDXX totaled $16.34 billion.
Zacks2 months ago
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
IDEXX Laboratories (IDXX) continues to boost investor confidence on strong companion animal business along with growth across all segments.
Markit2 months ago
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
Idexx Laboratories Inc NASDAQ/NGS:IDXX
GuruFocus.com2 months ago
IDEXX Laboratories Inc (IDXX) Files 10-K for the Fiscal Year Ended on December 31, 2017
IDEXX Laboratories Inc (NASDAQ:IDXX) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
PR Newswire2 months ago
IDEXX Laboratories to Present at Two Conferences
WESTBROOK, Maine , Feb. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate ...
Markit2 months ago
See what the IHS Markit Score report has to say about Idexx Laboratories Inc.
Idexx Laboratories Inc NASDAQ/NGS:IDXX
Thomson Reuters StreetEvents2 months ago
Edited Transcript of IDXX earnings conference call or presentation 1-Feb-18 1:30pm GMT
Q4 2017 IDEXX Laboratories Inc Earnings Call
GuruFocus.com2 months ago
Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $6. ...
Chairman, President & CEO of Idexx Laboratories Inc (NASDAQ:IDXX) Jonathan W Ayers sold 36,000 shares of IDXX on 02/06/2018 at an average price of $179.28 a share.
Zacks2 months ago
Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural
Zacks.com featured highlights include: Lululemon, Exelixis, IDEXX, Teradyne and Pioneer Natural
Zacks2 months ago
5 of the Best Efficient Stocks for Your Portfolio
Companies with a favorable efficiency level are expected to provide impressive returns as efficiency is believed to be positively correlated with price performance.
Zacks2 months ago
Second Sight (EYES) Catches Eye: Stock Jumps 12.7%
Second Sight (EYES) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.
Zacks2 months ago
IDEXX Laboratories Strong on CAG Business Amid Currency Woes
IDEXX's (IDXX) innovation-based global strategy is leading to growth at CAG Diagnostics.
Motley Fool2 months ago
IDEXX Laboratories Separates From the Pack
The animal-testing company is growing faster than its customers.
CNW Group2 months ago
IDEXX Advances Power of SediVue Dx with Latest Software Update
IDEXX Advances Power of SediVue Dx with Latest Software Update
PR Newswire2 months ago
IDEXX Advances Power of SediVue Dx with Latest Software Update
Neural Network 3.0 Brings Machine Learning, 70 Million Images into the Veterinary Practice for Faster, More Accurate Urine Sediment Analysis WESTBROOK, Maine , Feb. 5, 2018 /PRNewswire/ -- IDEXX Laboratories, ...
CNBC Videos2 months ago
Cramer's lightning round: My biggest worry about Allergan
Jim Cramer flies through his take on callers' favorite stocks, including a drug play he owns for his charitable trust.
CNBC Videos3 months ago
Cramer pinpoints 4 stocks 'on a mission' to higher prices...
Jim Cramer predicts that shares of Boeing, Mastercard, Idexx Laboratories and Nvidia could all hit lofty price targets in the near future.